ARTESp shows 62.5% positive clinical outcome after 90 days
The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischemic stroke. This was recently proven by four randomized controlled trials in patients with a proximal large vessel occlusion. The ARTESp study, recently published by Dr. Sascha Prothmann et al., mirrors and reinforces the findings of the above mentioned trials. ARTESp is a prospective, multicenter, single-arm Post Market Clinical Follow-up study in which the efficacy, the safety and the long-term outcomes of mechanical thrombectomy using the pREset® Thrombectomy Device were evaluated.
to our email news(max. one email per month)